Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you very much for following up with the company. I very much hope you will be able to share any explanation you receive which I am sure will be interesting.
Filled it. We can move on up now!
"The entire K trial and some great expected results is looking shady....
What total tosh.
from your reply to frrol:
"And everyone of those "investors" believed that their stock pick was the exception to the sleazy nature of the Pink Sheet market, just as people are convinced that CTIX is such an exception.
It may be, or it may not be".
Please let us know if you think "it may be".
Certainly is about time. For so long now the topic of conversation has been about dotting i's and crossing t's which is not what takes the stock higher. We are a drug discovery to drug approval company and the ultimate success of our drugs is what takes us much much higher.
I note a very tiny change of sentiment on here and a few are now talking of the exciting possibilities of good trial results that will be announced over the coming months.
Just think if Leo hadn't bought the Polymedix assets and Brilacidin hadn't shown so much promise or Kevetrin hadn't shrunk tumors and activated p53 we wouldn't have had a shark attack!!!
Unbelievable really.
Biotech is well known for the unexpected and large gap moves are common place.
Any bird with a hat on sounds good to me.
Hope you are right as Prurisol is the least discussed and a wild card for me.
Wishful thinking? Unless I have Dr Menon and Leo completely wrong this stock has so much potential I just don't believe it. Waiting for Dana-Farber to release blockbuster news for Kevetrin hopefuls and for Dr Trust to steer us onto the Phase 3 road for B-ABSSSI.
Looked like open and shut case.
Just from reading the PRs I remain extremely hopeful but realize that Dana-Farber hold the keys to this one and so I wait patiently for further (good) news. I am quite convinced there are many eyes on Kevetrin and that alone can be a complete company changer.
Not that I want to turn my back on it but this was settled.
Thanks for posting. Long and strong CTIX as below the decibels of constant bearish noise the various drug trials will soon add further support to this undervalued gem.
It gives the appearance of muck raking as it is old and is a pr from another company. That’s why.
"And how do your concerns affect current and future company operations"?
It's a fair question but I can't see how current and future operations of the company can be affected by them at all.
Happy New Year Everyone.
The focus is always the science and it's potential for monetary gain. $CTIX has that potential for massive gains and it's a pity that the conversation has to be bogged down by something that will be taken care of by the science.
It's not just an approved drug but a whole new class of antibiotics.
Truly Fantastic when it happens. Yes,and all for a company valued at less than $200m!!!!!
What I don't like about the dilution conversation is the total lack (by some) of the magnitude of the science and if we are successful what it means for shareholders.
The enormity of successfully trialling a new class of antibiotic drug is worth billions and add in anti-inflamitory drugs and you've got double that.
The enormity of successfully trialling a new oncology drug is worth multiple billions.
This is not for the weak kneed but it is why investors buy biotechs with great pipelines and take the risk.
Stay the course.
I hope nobody spotted the horrendous spelling mistake in my post# 135030!!!!
Did he really?
Did he come on here and pump it up?
I didn't think so.
Was Brilacidin going well in trials?
I thought so.
Did I chase it up not thinking the momentum might stop, be delayed like in all biotechs?
Yes I did.
So blame me and all the biotechies who thought a new antibiotic was fantastic news. Also, coupled with that Dana-Farber might release more fantastic news for Kevetrin?
Did I ever think someone would write a totally fallacious article about CTIX?
No I didn't
Has the science got better?
Yes
So what's the problem?
The end product(s) is potentially a 50 bagger or more for a successful CTIX so if I am diluted 100% and it only gets me a 25 bagger I'll take it.
Who said dilution was bad anyway, it's part of a biotech's DNA. I expect it and if we get any drug into the market because of it~then we did the right thing.
You could look at it another way~and that is that Leo financed through Aspire at higher prices than now with less dilution, which is good, and if he has to dilute at today's level it evens things out. But,I don't know that he has to do any financing at today's undervalued price and it could well recover before he has to.
The amount of money available (market cap in your example) doesn't change if the stock price changes but a lower price does mean more dilution. Dilution is inevitable but with one successful outcome the big pharmas will line up.
And if I am ever right...how excited you will be!
Happy Christmas Everybody
There is little doubt in my mind that the Brilacidin ABSSSI delay has caused a great opportunity for nefarious traders to advantage themselves. But as F1ash points out it is imperative to get it right the first time which is what I believe Leo are Dr Menon are doing and when we see the trial up and running the Brilacidin Buzz will be heard again.
Brilacidin Buzz (I like it)!
The downers are milking the downtrend for all it's worth but once the trend turns up there will be no looking back~~we are completely undervalued and there will be no looking back.
And best of all good bye downers.
2016 will be a banner year~~there is so much to report and a really good chance of a spectacular year.
I agree, terrible comment and completely untrue. The frustration level for a few on here seems to be bursting but what biotech doesn't frustrate it's shareholders. Either from a total lack of news (not in our case) or timelines being continually pushed out and bursting the bubble of over expectant shareholders. Blame is usually put on management but I would say the blame lies with both as shareholders, in their exuberance, are often unrealistic in their targets. CTIX has everything progressing well and is just as exciting, if not more, as when I first bought three years ago. Go $CTIX!
As much as I am disgusted by this lawsuit it pleased me to see that the Judge didn't give Rosen sixty days to otherwise fill in the blanks of an empty case,
The impression on here by those that attended was they came away very excited by K, P and B and we have a lot of good progress yet to be announced.
I think a sixty day extension is already baked in. Look for this to go better from here.
UOB was completely out of CTIX's control and you might want to look at the bigger picture than worry about minor details (Menon.)
$15!
I am consistently bullish on the sp, and therefore consistently wrong. I do not agree with those that say Leo is messing up. He has successfully undertaken so many trials with B ABSSSI going to Phase 3. I don't see the Rosen thing being any more than what those types of lawyers do. AND I AM MASSIVELY BULLISH ON THE SUCCESS OF B, K, and P.
Got it?
I cannot fathom where Leo has lost credibility as he is probably completely unknown to anyone outside this board. He certainly has not lost credibility with me as I don't see how he can hurry the science any faster than he and Dr Menon are already. It seems people don't understand how long trials take and don't understand the outstanding potential this tiny company has and are not prepared to wait for the potential to unfurl. Yes he has made mistakes but more is being made of them than the brilliant science they are developing.
How can one not be suspicious of people citing hit pieces, it seems ridiculous to me as B ABSSSI time line is already old news and UOB is is unfortunate but not totally unexpected.
If we concentrate on the incredible science that CTIX have we shouldn't have to worry about the immoral attackers of our company. The science is bigger than all of them. The future looks great.